# Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

> clinical trial · VERIFIED · 2026-07-02

Status: NOT_YET_RECRUITING · Sponsor: BrainChild Bio, Inc · Condition: Diffuse Intrinsic Pontine Glioma

- Company: BrainChild Bio, Inc
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07680439

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.